EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating microRNAs as Biomarkers of Various Forms of Epilepsy

Elena E Timechko iD, Kristina D Lysova iD, Alexey M Yakimov iD, Anastasia I Paramonova, Anastasia A Vasilieva iD, Elena A Kantimirova, Anna A Usoltseva iD, Albina V Yakunina, Irirna G Areshkina, Diana V Dmitrenko iD

Medical Sciences · 08.01.2025 · 13 (1) · 7

DOI: 10.3390/medsci13010007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 08.01.2025. Verfasst von Elena E Timechko und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Clinical Neurophysiology of Postgraduate Education, V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University, Russi…. Hauptthemen laut MEDLINE: Circulating MicroRNA, MicroRNAs, Epilepsy, Epilepsy, Temporal Lobe. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of the Russian Federation, Identification of predictors of drug-resistant course and outcomes of surgical treatment of epilepsy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epilepsy is a group of disorders characterized by a cluster of clinical and EEG signs leading to the formation of abnormal synchronous excitation of neurons in the brain. It is one of the most common neurological disorders worldwide; and is characterized by aberrant expression patterns; both at the level of matrix transcripts and at the level of regulatory RNA sequences. Aberrant expression of a number of microRNAs can mark a particular epileptic syndrome; which will improve the quality of differential diagnosis. Materials and Methods: In this work; the expression profile of six microRNAs was analyzed: hsa-miR-106b-5p; hsa-miR-134-5p; hsa-miR-122-5p; hsa-miR-132-3p; hsa-miR-155-5p; and hsa-miR-206-5p in the blood plasma of patients suffering from temporal lobe epilepsy (n = 52) and juvenile myoclonic epilepsy (n = 42); n—amount of participants; in comparison with healthy volunteers. The expression analysis was carried out using RT-PCR. Mathematical processing of the data was carried out according to the Livak method.

Results

A statistically significant change in the expression of hsa-miR-106b-5p; hsa-miR-134-5p; hsa-miR-122-5p; and hsa-miR-132-3p was found. An increase in the expression of hsa-miR-134-5p and hsa-miR-122-5p was registered in the group of patients with temporal lobe epilepsy compared to the control; as well as an increase in the expression of hsa-miR-132-3p and hsa-miR-106b-5p in the juvenile myoclonic epilepsy group compared to the control. hsa-miR-122-5p; 106b-5p; 132-3p are also able to discriminate groups with different syndromes. Additionally; a number of microRNAs are able to discriminate patients with drug-resistant and drug-sensitive forms of epilepsy from the control; as well as patients with hippocampal sclerosis and patients without hippocampal sclerosis from the control.

Conclusion

Our data allow us to propose these microRNAs as plasma biomarkers of various epileptic syndromes

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating MicroRNAMicroRNAsEpilepsyEpilepsy, Temporal LobeMyoclonic Epilepsy, JuvenileHumansBiomarkersFemaleMaleAdultMiddle AgedYoung AdultAdolescentCase-Control Studies

Stichwörter der Autor:innen

biomarkersdrug-resistanceexpression profilejuvenile myoclonic epilepsymicroRNAtemporal lobe epilepsy

Substanzen

BiomarkersCirculating MicroRNAMicroRNAs

Autor:innen und Institutionen

  • Department of Medical Genetics, Clinical Neurophysiology of Postgraduate Education, V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University, Russian National Research, Krasnoyarsk 660022, Russia.
  • Federal State Budgetary Educational Institution, Samara State Medical University, Ministry of Healthcare of the Russian, Samara 443079, Russia.

ORCID-Profile: Elena E Timechko, Kristina D Lysova, Alexey M Yakimov, Anastasia A Vasilieva, Anna A Usoltseva, Diana V Dmitrenko

Förderung

  • Ministry of Health of the Russian Federation
  • Identification of predictors of drug-resistant course and outcomes of surgical treatment of epilepsy

Zitieren

APA

Timechko, E. E., Lysova, K. D., Yakimov, A. M., Paramonova, A. I., Vasilieva, A. A., Kantimirova, E. A., Usoltseva, A. A., Yakunina, A. V., Areshkina, I. G., & Dmitrenko, D. V. (2025). Circulating microRNAs as Biomarkers of Various Forms of Epilepsy. Medical Sciences, 13(1), 7. https://doi.org/10.3390/medsci13010007

Vancouver

Timechko EE, Lysova KD, Yakimov AM, Paramonova AI, Vasilieva AA, Kantimirova EA, et al. Circulating microRNAs as Biomarkers of Various Forms of Epilepsy. Medical Sciences. 2025;13(1):7. doi:10.3390/medsci13010007

BibTeX
@article{Timechko2025,
  author = {Timechko, Elena E and Lysova, Kristina D and Yakimov, Alexey M and Paramonova, Anastasia I and Vasilieva, Anastasia A and Kantimirova, Elena A and Usoltseva, Anna A and Yakunina, Albina V and Areshkina, Irirna G and Dmitrenko, Diana V},
  title = {Circulating microRNAs as Biomarkers of Various Forms of Epilepsy},
  journal = {Medical Sciences},
  year = {2025},
  volume = {13},
  number = {1},
  pages = {7},
  doi = {10.3390/medsci13010007}
}
Kostenlos starten →